{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,4,27]],"date-time":"2024-04-27T13:58:55Z","timestamp":1714226335197},"reference-count":19,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2017,1,5]]},"DOI":"10.4103\/0366-6999.196585","type":"journal-article","created":{"date-parts":[[2017,2,17]],"date-time":"2017-02-17T12:02:29Z","timestamp":1487332949000},"page":"1-3","source":"Crossref","is-referenced-by-count":2,"title":["Improvement of Malignant Pleural Mesothelioma Prognosis"],"prefix":"10.1097","volume":"130","author":[{"given":"Cheng-Jun","family":"Ban","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Huan-Zhong","family":"Shi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yu-Hui","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-1-20210129","doi-asserted-by":"crossref","first-page":"13618","DOI":"10.1073\/pnas.1105887108","article-title":"Erionite exposure in North Dakota and Turkish villages with mesothelioma","volume":"108","author":"Carbone","year":"2011","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R2-1-20210129","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1007\/s10653-012-9504-9","article-title":"Geologic occurrences of erionite in the United States: An emerging national public health concern for respiratory disease","volume":"35","author":"Van Gosen","year":"2013","journal-title":"Environ Geochem Health"},{"key":"R3-1-20210129","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1097\/JTO.0000000000000506","article-title":"The presence of asbestos in the natural environment is likely related to mesothelioma in young individuals and women from Southern Nevada","volume":"10","author":"Baumann","year":"2015","journal-title":"J Thorac Oncol"},{"key":"R4-1-20210129","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1158\/0008-5472.CAN-15-0295","article-title":"Germline BAP1 mutational landscape of asbestos-exposed malignant mesothelioma patients with family history of cancer","volume":"76","author":"Ohar","year":"2016","journal-title":"Cancer Res"},{"key":"R5-1-20210129","doi-asserted-by":"crossref","first-page":"716","DOI":"10.2471\/BLT.11.086678","article-title":"Global mesothelioma deaths reported to the World Health Organization between 1994 and 2008","volume":"89","author":"Delgermaa","year":"2011","journal-title":"Bull World Health Organ"},{"key":"R6-1-20210129","first-page":"825","article-title":"Clinicopathological characteristics and prognosis of malignant pleural mesothelioma (in Chinese)","volume":"36","author":"Chen","year":"2013","journal-title":"Chin J Tuberc Respir Dis"},{"key":"R7-1-20210129","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1001\/archinte.1984.00350140139020","article-title":"Sensitivity, specificity, and predictive values of closed pleural biopsy","volume":"144","author":"Poe","year":"1984","journal-title":"Arch Intern Med"},{"key":"R8-1-20210129","first-page":"E254","article-title":"Guidelines for the diagnosis and treatment of malignant pleural mesothelioma","volume":"5","author":"van Zandwijk","year":"2013","journal-title":"J Thorac Dis"},{"key":"R9-1-20210129","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1159\/000435962","article-title":"Efficacy and safety of diagnostic thoracoscopy in undiagnosed pleural effusions","volume":"90","author":"Wang","year":"2015","journal-title":"Respiration"},{"key":"R10-1-20210129","doi-asserted-by":"crossref","first-page":"2081","DOI":"10.1200\/JCO.2008.19.8523","article-title":"Malignant pleural mesothelioma","volume":"27","author":"Tsao","year":"2009","journal-title":"J Clin Oncol"},{"key":"R12-1-20210129","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1016\/S0140-6736(15)01238-6","article-title":"Bevacizumab for newly diagnosed pleural mesothelioma in the Mesothelioma Avastin Cisplatin Pemetrexed Study (MAPS): A randomised, controlled, open-label, phase 3 trial","volume":"387","author":"Zalcman","year":"2016","journal-title":"Lancet"},{"key":"R13-1-20210129","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.critrevonc.2016.05.004","article-title":"The Third Italian Consensus Conference for Malignant Pleural Mesothelioma: State of the art and recommendations","volume":"104","author":"Novello","year":"2016","journal-title":"Crit Rev Oncol Hematol"},{"key":"R14-1-20210129","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1016\/j.ctrv.2012.11.004","article-title":"Second Italian consensus conference on malignant pleural mesothelioma: State of the art and recommendations","volume":"39","author":"Pinto","year":"2013","journal-title":"Cancer Treat Rev"},{"key":"R15-1-20210129","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.lungcan.2014.03.006","article-title":"Vinorelbine and gemcitabine as second-or third-line therapy for malignant pleural mesothelioma","volume":"84","author":"Zauderer","year":"2014","journal-title":"Lung Cancer"},{"key":"R16-1-20210129","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1007\/s10147-013-0619-5","article-title":"Gemcitabine and vinorelbine as second-line or beyond treatment in patients with malignant pleural mesothelioma pretreated with platinum plus pemetrexed chemotherapy","volume":"19","author":"Toyokawa","year":"2014","journal-title":"Int J Clin Oncol"},{"key":"R17-1-20210129","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1053\/j.ro.2013.03.017","article-title":"Malignant pleural mesothelioma: Role of CT, MRI, and PET\/CT in staging evaluation and treatment considerations","volume":"48","author":"Truong","year":"2013","journal-title":"Semin Roentgenol"},{"key":"R18-1-20210129","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.jtho.2015.11.005","article-title":"The 2015 World Health Organization classification of tumors of the pleura: Advances since the 2004 classification","volume":"11","author":"Galateau-Salle","year":"2016","journal-title":"J Thorac Oncol"},{"key":"R19-1-20210129","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1097\/JTO.0b013e31823f45c1","article-title":"Inflammation-based prognostic indices in malignant pleural mesothelioma","volume":"7","author":"Pinato","year":"2012","journal-title":"J Thorac Oncol"},{"key":"R20-1-20210129","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1007\/s11307-010-0426-6","article-title":"Current evidence base of FDG-PET\/CT imaging in the clinical management of malignant pleural mesothelioma: Emerging significance of image segmentation and global disease assessment","volume":"13","author":"Basu","year":"2011","journal-title":"Mol Imaging Biol"}],"container-title":["Chinese Medical Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.4103\/0366-6999.196585","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,6,17]],"date-time":"2021-06-17T19:41:59Z","timestamp":1623958919000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00029330-201701050-00001"}},"subtitle":["Early Diagnosis and Multimodality Treatment"],"short-title":[],"issued":{"date-parts":[[2017,1,5]]},"references-count":19,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017]]}},"URL":"https:\/\/doi.org\/10.4103\/0366-6999.196585","relation":{},"ISSN":["0366-6999"],"issn-type":[{"value":"0366-6999","type":"print"}],"subject":[],"published":{"date-parts":[[2017,1,5]]}}}